title: Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
authors.affiliation: Department of Surgery, Notre-Dame Hospital, Montreal, Québec, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Smeesters
authors.forename: P
authors.initials: P
authors.lastname: Chaland
authors.forename: L
authors.initials: L
authors.lastname: Giroux
authors.forename: J M
authors.initials: JM
authors.lastname: Moutquin
authors.forename: P
authors.initials: P
authors.lastname: Etienne
authors.forename: F
authors.initials: F
authors.lastname: Douglas
authors.forename: J
authors.initials: J
authors.lastname: Corman
authors.forename: G
authors.initials: G
authors.lastname: St-Louis
authors.forename: P
authors.initials: P
authors.lastname: Daloze
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000037:antagonists & inhibitors* / Q000097:blood; D015232:Dinoprostone; D007668:Kidney / Q000187:drug effects*; D011458:Prostaglandins E / Q000652:urine; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D013929:Thromboxane B2 / Q000652:urine; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
chemical_list: D003524:Cyclosporins; D011458:Prostaglandins E; D011725:Pyridines; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C049113:3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid; D003404:Creatinine; D013930:Thromboxane-A Synthase; D015232:Dinoprostone